Ciara Catherine O'Sullivan

10PUBLICATIONS
86CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Social program evaluationClinical midwiferyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 20, 2026
Pathologic Complete Response (pCR) Rate and Predictors of Response to Taxane, Trastuzumab, and Pertuzumab in HER2‑Positive Breast Cancer: Secondary Analyses of EA1181/CompassHER2 pCR.

|May 25, 2026
Associations of spousal support with career attrition in academic medicine: a multi-specialty cross-sectional survey study.

|Dec 10, 2025
HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer.

Veronique Dieras, Giuseppe Curigliano, Miguel Martin

|May 16, 2024
Anastrozole Dose Escalation for Optimal Estrogen Suppression in Postmenopausal Early-Stage Breast Cancer: A Prospective Trial.

Tufia C Haddad, Vera J Suman, Karthik V Giridhar

|Jul 11, 2023
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP.

Jennifer K Litton, Meredith M Regan, Lajos Pusztai

|Jun 23, 2023
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME Model.

Sibel Blau, Julio Antonio Peguero, Halle C F Moore

Pageof 2

Frequent Collaborators

2 joint publications

Kathryn J Ruddy

1 joint publications

Grace M Choong

1 joint publications

Grace D Cullen

1 joint publications

Daniel S Childs